Health Care Costs Associated With First- And Second-Line Switching Of Biologic Disease-Modifying Antirheumatic Drugs
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1127
https://www.valueinhealthjournal.com/article/S1098-3015(13)01198-4/fulltext
Title :
Health Care Costs Associated With First- And Second-Line Switching Of Biologic Disease-Modifying Antirheumatic Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01198-4&doi=10.1016/j.jval.2013.03.1127
First page :
A222
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
702